In other disease models including idiopathic pulmonary fibrosis and liver cirrhosis, LOXL1 was shown to be stimulated by pro-fibrotic TGFB to increase cross-linking, and its knockdown protects from fibrosis and reduces expression of pro-fibrotic metalloproteases and collagens (27). Here, LOXL1 is linked to pulmonary fibrosis.